期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

利奈唑胺在血液病患者革兰阳性菌感染抗菌治疗中的临床应用 被引量：3

原文传递
导出
摘要 血液病患者自身常存在免疫功能缺陷，而化疗药物和免疫抑制剂的应用，又可引起骨髓抑制、加重免疫功能缺陷，使得感染的发生率和病死率极高。在我国，血液科住院患者感染率达34％，其中超过70％为院内获得性感染。
作者 黄晓军
机构地区 北京大学人民医院血液科北京大学血液病研究所
出处 《中华内科杂志》 CAS CSCD 北大核心 2013年第3期260-263,共4页 Chinese Journal of Internal Medicine
关键词 革兰阳性菌感染 血液病患者 临床应用 抗菌治疗 利奈唑胺 免疫功能缺陷 院内获得性感染 免疫抑制剂
分类号 R446.5 [医药卫生—诊断学]
  • 相关文献

参考文献26

  • 1韩冰,邸海峡,周道斌,赵永强,王书杰,许莹,陈嘉林,段云,焦力,段明辉,张薇,朱铁楠,邹农,沈悌.1993—2004年血液病房2388例次住院患者感染分析[J].中华医学杂志,2006,86(10):664-668. 被引量：22
  • 2韩冰,邸海侠,周道斌,赵永强,王书杰,许莹,陈嘉林,段云,焦力,段明辉,张薇,朱铁楠,邹农,沈悌.血液科2388例次住院患者感染危险因素的分析[J].北京医学,2007,29(6):327-329. 被引量：21
  • 3Kosmidis CI, Chandrasekar PH. Management of gram-positive bacterial infections in patients with cancer. Leuk Lymphoma, 2012,53:8-18.
  • 4Leach KL, Brickner SJ, Noe MC, et al. Linezolid, the first oxazolidinone antibacterial agent. Ann N Y Acad Sci ,2011,1222: 49 -54.
  • 5Ross JE, Farrell DJ, Mendes RE, et al. Eight-year (2002-2009) summary of the linezolid (Zyvox(R) Annual Appraisal of Potency and Spectrum ; ZAAPS ) program in European countries. J Chemother, 2011,23:71-76.
  • 6Zhao C, Sun H, Wang H, et al. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (:2005- 2010). Diagn Microbiol Infect Dis,2012,73:17d-181.
  • 7Conte JE Jr, Golden JA, Kipps J, et al. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother, 2002,46 : 1475-1480.
  • 8Gee T, Ellis R, Marshall G, et al. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother, 2001,45 : 1843-1846.
  • 9Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother, 2011,66 Suppl 4 : iv7-ivlS.
  • 10ZYVOX ( linezolid ) FDA Prescribing Information [ DB/OL ]. [ 2012-12-31 ]. http : www. accessdata, fda. gov/.

二级参考文献32

共引文献66

同被引文献34

  • 1Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practiceguideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis, 2011, 52(4) :e56-93.
  • 2Fu J, Ye X, Chen C, et al. The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus anreus infections[J]. PLoS One, 2013, 8(3):e58240.
  • 3Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study [ J]. Clin Infect Dis, 2012, 54 (5) :621-629.
  • 4Itani KM, Dryden MS, Bhattacharyya H, et al. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus[ J]. Am J Surg, 2010, 199(6) :804-816.
  • 5Wilcox MH, Tack K J, Bouza E, et al. Complicated skin and skin- structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study [ J ]. Clin Infect Dis, 2009, 48(2) :203-212.
  • 6Wunderink RG, Mendelson MH, Somero MS, et al. Early microbiological response to linezolid vs vancomycin in ventilator- associated pneumonia due to methicillin-resistant Staphylococcus aureus [ J ]. Chest, 2008, 134 (6) : 1200-1207.
  • 7Lin DF, Zhang YY, Wu JF, et al. Linezolid for the treatment of infections caused by Gram-positive pathogens in China [ J ]. Int J Antimicrob Agents, 2008, 32 (3) :241-249.
  • 8Kohno S, Yamaguchi K I Aikawa N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin- resistant Staphylococcus aureus in Japan [ J ]. J Antimicrob Chemother, 2007, 60(6):1361-1369.
  • 9Weigelt J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections [ J ]. Antimicrob Agents Chemother, 2005, 49 (6) :2260-2266.
  • 10桑福德.抗微生物治疗指南:热病[M].范洪伟,译.40版.北京:中国协和医科大学出版社,2010.

引证文献3

二级引证文献10

中华内科杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部